Akgun, Z.; Cakir, A.; Sağlam, E.; Demirel, S.; Igci, A.; Keskin, S.
A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality. Medicina 2023, 59, 675.
https://doi.org/10.3390/medicina59040675
AMA Style
Akgun Z, Cakir A, Sağlam E, Demirel S, Igci A, Keskin S.
A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality. Medicina. 2023; 59(4):675.
https://doi.org/10.3390/medicina59040675
Chicago/Turabian Style
Akgun, Zuleyha, Aydin Cakir, Esra Sağlam, Sertac Demirel, Abdullah Igci, and Serkan Keskin.
2023. "A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality" Medicina 59, no. 4: 675.
https://doi.org/10.3390/medicina59040675
APA Style
Akgun, Z., Cakir, A., Sağlam, E., Demirel, S., Igci, A., & Keskin, S.
(2023). A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality. Medicina, 59(4), 675.
https://doi.org/10.3390/medicina59040675
